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The tremendous foundation of microbiome sequencing data is 
propelling human microbiota studies into a second phase focused 
on function and mechanism. Recently published metagenomic 
data highlight the overlap and conservation of core function-
alities within the intestinal microbiome of different individuals 
(Turnbaugh et al., 2007, 2009). This similarity embedded within the 
combined genomes of different consortia reveals that each person’s 
gut is endowed with a core set of genes (a core microbiome) that 
carry out functions common to the human intestine. This new 
phase of investigation, which is focused on the emergent proper-
ties of the host–microbial super-organism, is attracting biomedical 
scientists from diverse fields, including virologists.
A well-supported cAse for microbiotA impAct on 
pAthogen susceptibility
The ability of an orally acquired pathogen to cause disease is depend-
ant upon multiple steps that the microbiota may influence. A patho-
gen must navigate through the dense community of microbes, gain 
access to the epithelial surface, and manage the ensuing immune 
response. Commensal microbes present significant competition for 
nutrients (Sonnenburg et al., 2006), secrete microbicidal proteins 
(Corr et al., 2007), and elicit host responses that are fundamental to 
the development and maintenance of the mucosal innate and adap-
tive immune system (Cebra, 1999; Hooper et al., 2001; Ivanov et al., 
2009). Despite this seemingly inhospitable environment, pathogens 
can gain access to host tissue and cause disease.
The role of the intestinal microbiota in reducing host susceptibil-
ity to enteric bacterial pathogens is commonly referred to as “coloni-
zation resistance,” although the underlying  mechanisms are poorly 
the intestinAl microbiotA
A staggering number of microbes reside in and upon the human body 
(Dethlefsen et al., 2007). Our co-evolution with this microbiota has 
resulted in the integration of microbially derived developmental cues 
and metabolic capacities into human biology (Backhed et al., 2005). 
The vast majority of the 10–100 trillion microbial cells that inhabit 
the human body are found within the distal digestive tract. An altered 
intestinal microbiota composition has been linked to numerous patho-
logic states such as inflammatory bowel diseases and obesity in mouse 
models and in humans (Ley et al., 2005, 2006; Frank et al., 2007). In 
some cases an etiological relationship between the microbiota and 
disease state has been established (Turnbaugh et al., 2006; Garrett et al., 
2007; Vijay-Kumar et al., 2010). Thus, human biology and health are 
intimately intertwined with the biology of our microbial inhabitants.
Ongoing large-scale sequencing efforts are providing a com-
prehensive sequence-based definition of this intestinal microbiota 
(Qin et al., 2010). Typically two bacterial phyla dominate the healthy 
Western adult intestine, the Firmicutes and Bacteroidetes compose 
>90% of the bacterial cells. Proteobacterium and Bifidobacterium 
and a handful of other bacterial phyla make up the remainder of 
the community, along with members of Archaea and Eukaryota. 
Despite the limited representation of bacterial phyla, at finer scales 
of phylogenetic resolution, such as species and strain, the intestinal 
microbiota is highly diverse and exhibits substantial compositional 
variability between people, and thus represents an “individualized 
fingerprint.” In addition to inter-individual variability, the microbi-
ota exhibits temporal variability, likely due to the numerous factors 
that continually perturb this dynamic microbial ecosystem, such as 
changes in host diet and introduction of orally acquired pathogens.
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understood. The increased susceptibility of oral  antibiotic-treated 
mice or humans to enteric infection nicely illustrates the potential 
impact of microbiota perturbation on pathogen emergence (Pavia 
et al., 1990; Barthel et al., 2003; Doorduyn et al., 2006; Lawley et al., 
2009). Furthermore, treating infectious diarrheas with live micro-
bial supplements (i.e., probiotics) has proven successful in decreas-
ing the duration of symptoms, but the mechanisms of action and 
whether such treatment is more effective for certain causative agents 
(e.g., bacterial vs. viral) remain obscure (Servin, 2004; Vandenplas 
et al., 2007; Guandalini, 2008; Allen et al., 2010). Together, these data 
support that alterations in host-associated microbial communities 
can impact an ensuing interaction with a pathogen.
intestinAl microbiotA influences immune function 
And pAthogen susceptibility
The gut microbiota influences the status of the host immune system 
during development and throughout life. The host typically main-
tains a dynamic and attenuated physiological state of inflammation 
in the mucosa that is tuned to the membership of the adjacent 
microbial community (Cebra, 1999). Disruption of the microbiota-
dependent homeostasis can be deleterious to the host. For example, 
in an experimental model of chemically induced intestinal epithelial 
injury, cell damage is exacerbated in the absence of a microbiota or 
if the mice are deficient in Myd88, an adaptor protein critical for 
toll-like, receptor-mediated recognition of the commensal micro-
biota (Rakoff-Nahoum et al., 2004). Similarly, Salmonella-induced 
inflammation becomes more severe in the absence of an intestinal 
microbial community (Stecher et al., 2005). Antimicrobial protein 
secretion (Hooper et al., 2001), induction of secretory IgA (Moreau 
et al., 1978; Shroff et al., 1995), Th1:Th2 bias (Mazmanian et al., 
2005), and recruitment of the myeloid and lymphoid cell lineages 
to the gut (Cebra et al., 1998; Zaph et al., 2008) are impacted by 
microbial signals derived from the microbiota.
Therefore, aspects of mucosal and systemic immunity are similar 
in concept to a rheostat, with the microbiota playing a significant 
role in modulating the set-point. The concept that microbial modu-
lation of the immune system can alter pathogen susceptibility is 
illustrated in a mouse model of latent herpesvirus infection. In this 
model, the latent virus is capable of elevating steady state levels of 
IFN-γ, effectively altering the set-point of the immune system and 
decreasing the host susceptibility to intracellular bacterial patho-
gens (Barton et al., 2007). The increased resistance to Listeria mono-
cytogenes and Yersinia pestis of mice harboring latent herpesvirus 
implies that such dormant viruses (most humans possess several 
such herpesviruses) may be viewed as symbionts with mutualistic 
potential. These data are also suggestive that these same principles 
may apply to the microbiota: specifically, host immune status may 
be modulated by commensal microbes prior to pathogen exposure 
to alter host resistance to infection.
Since the vast majority of infections begin at the mucosal 
surface, it is not surprising that pathogen susceptibility may be 
impacted by the presence or absence of resident microbes that 
are capable of influencing local and systemic aspects of immu-
nity. Segmented filamentous bacteria (SFB), an intestinal resident 
of mice, were recently identified as necessary and sufficient to 
induce Th17 development in the gut (Ivanov et al., 2009). In this 
same study, the presence of SFB proved critical in minimizing 
the inflammation caused by a colitis-inducing bacterial pathogen, 
Citrobacter  rodentium. Similarly, alteration in host susceptibility 
to respiratory infection following intestinal exposure to a spe-
cific microbe has been reported. In an experimental model of 
Cryptococcus neoformans-induced pulmonary eosinophilia, the 
Th2-driven pathology can be abrogated by prior introduction of 
C. rodentium into the digestive tract (Williams et al., 2006). C. 
rodentium inflammation induces a Th1-response, which reduces 
the Th2-skewing and C. neoformans-associated pulmonary inflam-
mation. This protective effect is lost if mice are colonized with 
a mutant strain of C. rodentium that is deficient in the intimin 
receptor, and therefore is incapable of attaching to the host colonic 
epithelium and unable to induce a Th1 response. Similarly, mul-
tiple studies have illustrated the ability of either chronic or acute 
parasitic infection in the intestine to influence immune responses 
in the lung, specifically decreasing allergic airway inflammation 
(Wilson et al., 2005; Kitagaki et al., 2006; Gibbons et al., 2009). 
The ability of a group of Clostridium species to induce regula-
tory T-cells in the colon and decrease the severity of colitis and 
IgE responses in a mouse model further affirms the role of gut 
microbes in modulating aspects of mucosal and systemic immune 
function (Atarashi et al., 2010).
the microbiotA’s direct influence on pAthogens
In addition to acting through the immune system, the intestinal 
microbiota may impact pathogens more directly. The emergence 
of bacterial pathogens, such as Clostridium difficile and Salmonella 
spp., during or shortly after antibiotic treatment, suggests the loss 
of inhibitory effects of the microbiota upon antibiotic-induced 
disruption. Several bacterial pathogens, such as Salmonella and 
Citrobacter, appear to subvert the host immune response within 
the intestine causing persistent microbiota disruption thus aiding 
their own proliferation (Lupp et al., 2007; Stecher et al., 2007). 
Competing for nutrients, physically obstructing access to the 
mucosa, and producing antimicrobial proteins have all been pro-
posed as mechanisms that contribute to colonization resistance 
(Stecher and Hardt, 2008). The bacteriocin, Abp118, produced by 
a Lactobacillus salivarius strain, is capable of killing L. monocy-
togenes, and its production in vivo is required to protect the host 
in a murine model of oral Listeria infection (Corr et al., 2007). 
This example provides a glimpse of the type of warfare that can 
take place amongst and between permanent and transient gut resi-
dents. Alternatively, egg hatching of Trichuris muris, a nematode 
that invades the intestinal epithelium of mice, is enhanced in the 
presence of the microbiota-derived microbes in vitro, and T. muris 
burden is decreased after antibiotic knock-down of the microbiota 
(Hayes et al., 2010). The ability of multiple pathogens to infect in 
the absence of apparent microbiota disruption (i.e., not all orally 
acquired pathogens require antibiotic treatment to emerge and 
cause disease) suggests that several infectious agents may be adapted 
to and benefit from the microbiota in a normal state.
potentiAl impAct of the microbiotA on virAl 
infections
In general, the microbiota may enhance viral infection, reduce 
viral infection, or have no effect on viral infection. In instances 
when the microbiota influences viral infection, it may be via direct 
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microbiota may have direct and indirect effects for enteric viruses 
that directly encounter them in the intestinal lumen (enterovirus, 
rotavirus, Norwalk virus, astrovirus, etc.). However, the intestinal 
microbiota may also impact non-enteric viruses through indirect 
mechanisms. Several viruses encounter host–microbiota at other 
body sites, such as skin and the genital tract (HIV, papilloma virus, 
herpes simplex virus, etc.). Therefore, microbiota may affect a wide 
variety of viruses through diverse mechanisms (Figure 1).
The first step is to determine the impact of the microbiota on 
various viruses by depleting the microbiota and quantifying viral 
replication and pathogenesis. Mouse models will be very useful for 
these experiments, provided that there is an appropriate mouse 
model for the virus of interest. Mice are naturally resistant to many 
pathogens, including viruses, often requiring the use of immu-
nodeficient or neonatal mice for pathogenesis studies. Therefore, 
diverse systems may be required to overcome this “species barrier.” 
Microbiota depletion can be accomplished with broad-spectrum 
antibiotic treatment or the use of germ-free animals. Antibiotic 
treatment is an attractive option since it is relatively simple and 
inexpensive and can be used with any animal model. However, 
in antibiotic-treated animals, microbiota clearance is incomplete, 
the ratios of various species are altered, and the antibiotics can 
indirectly alter the host via microbiota-independent effects (Rakoff-
Nahoum et al., 2004). Another negative is that antibiotic-mediated 
microbiota clearance requires 1 week or more, and since neonatal 
mice are required for some viral pathogenesis models, the antibiotic 
model is not ideal. Using germ-free mice overcomes many of these 
obstacles. Germ-free mice are completely microbiologically sterile, 
eliminating background and allowing recolonization with specific 
microbes to examine specificity of microbiota effects. However, 
germ-free mice require highly specialized facilities, are expensive, 
and a limited number of germ-free mouse strains are available. 
Additionally, germ-free mice have immature immune systems and 
altered intestinal physiology, which may complicate interpretation 
of experiments (Smith et al., 2007). A combination of experiments 
with antibiotic-treated mice and germ-free mice may be neces-
sary to paint a complete picture of microbiota effects on viruses. 
Retrospective and/or prospective studies on humans treated with 
antibiotics and their incidence of viral infections may also be useful 
in evaluating microbiota effects on viruses.
Once the impact of the microbiota has been established for a 
given virus, the second step is to determine whether effects occur 
through direct or indirect mechanisms. The microbiota may 
directly alter the infectivity of viral particles through virion modi-
fication or processing. Microbial components or products may 
interact with virions to enhance or reduce their infectivity. It is also 
possible that virions may “hitchhike” on motile bacteria to access 
host cells. Conversely, the microbiota may indirectly influence viral 
infection by altering the host. For example, the microbiota may 
promote or limit viral replication by altering innate and/or adap-
tive immune responses, changing the susceptibility of host cells, 
or altering viral receptor expression. A variety of experimental 
systems will be useful to determine the nature of microbiota effects 
on viruses. For example, direct effects of microbiota on virions can 
be examined through in vitro mixing experiments and infectivity 
assays. Indirect microbiota effects on viruses mediated by innate 
immune responses can be examined in mouse strains lacking 
mechanisms, such as virion modification, or indirect mechanisms, 
such as host cell modification. Direct effects of the microbiota on 
viruses are likely to occur locally, whereas indirect effects may occur 
locally or systemically.
Several studies have shown that the microbiota has the potential to 
reduce viral infection and disease. First, germ-free mice have enhanced 
susceptibility to influenza A virus (Dolowy and Muldoon, 1964), cox-
sackie B virus (Schaffer et al., 1963), and Friend virus (Mirand and 
Grace, 1963), which suggests that the microbiota directly or indirectly 
limits disease in mice with a conventional flora. Second, while dengue 
virus is a blood-borne pathogen in mammals, it initiates mosquito 
infection through the enteric route. Interestingly, dengue virus rep-
lication is enhanced in the midguts of antibiotic-treated mosquitoes, 
which suggests that the insect microbiota limits viral replication. 
These effects may occur indirectly via microbiota-mediated anti-viral 
immune activation through the Toll pathway (Xi et al., 2008). Third, 
adenovirus replication is inhibited by defensins, which are antimi-
crobial peptides produced by the host in response to the microbiota 
(Gropp et al., 1999). Defensins directly bind adenovirus virions and 
limit replication in vitro (Smith and Nemerow, 2008). Therefore, the 
microbiota may limit adenovirus infection through induction of host 
defense mechanisms, although the effects of defensins on enteric 
viruses in vivo is unknown.
Conversely, several studies have shown that microbial prod-
ucts can indirectly enhance viral replication and disease. First, 
persistence of mouse mammary tumor virus is enhanced by 
lipopolysaccharide (LPS), a component of Gram-negative bac-
teria. LPS activates the innate immune pathways culminating in 
IL-10-mediated tolerance and viral persistence in mice (Jude et al., 
2003). Second, Theiler’s murine encephalitis virus-induced repli-
cation and disease in the central nervous system is enhanced by 
treatment with LPS. These effects likely occur through indirect 
mechanisms involving increased inflammation in the central nerv-
ous system, which promotes viral replication (Pullen et al., 1995). 
In future work, it will be important to determine whether native 
microbiota-derived LPS, rather than experimentally administered 
LPS, is sufficient to promote viral infection. Third, human immu-
nodeficiency virus (HIV) pathogenesis and progression to acquired 
immunodeficiency syndrome (AIDS) is enhanced by LPS-mediated 
chronic immune activation from microbial translocation through 
the intestinal wall (Brenchley et al., 2006). Therefore, the micro-
biota may indirectly enhance progression to AIDS through indirect 
immune activation mechanisms.
When considering effects of the microbiota on viruses, it is 
important to be mindful of the evolutionary potential of viruses, 
particularly RNA viruses. Viruses have error frequencies up to a 
million-fold higher than bacteria or mammals and likely evolved 
to replicate in their respective niches, including niches containing 
a microbiota. Thus, the hypothesis that some viruses will generally 
fare worse in the absence of the microbiota with which they have 
evolved will be important to test using microbiota-deficient mice.
gAps thAt need to be Addressed for the field to move 
forwArd
Clearly, it is important to understand how the microbiota influences 
viral infections, but what are the major questions to address? The 
questions will be shaped by virus type. For example, the intestinal 
Pfeiffer and Sonnenburg Viruses and the intestinal microbiota
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The possibility of leveraging the microbiota’s role in infectious 
disease as a platform to alter the course of infections presents many 
important questions. Can we rationally and reproducibly manipu-
late the composition and function of our intestinal microbiota? Can 
this manipulation be performed in ways that prevent or ameliorate 
human disease? To address these questions, it is critical to lay a 
foundation of basic research that will establish the fundamental 
principles that govern this complex set of interactions. Highly con-
trolled studies in model system are needed to establish how the 
gut microbiota may be manipulated rationally through the use of 
orally administered microbes (probiotics), dietary supplementa-
tion (prebiotics), and/or microbiota-targeted small molecules to 
optimize host resistance to infectious disease.
As we expand our understanding of pathogens that possess 
diverse routes of invasion, tropisms, and/or toxins, and we inves-
tigate how this biology intersects with the host–microbiota interac-
tion, strategies for using this information to improve human health 
will become evident. For example, interferon (IFN) signaling is an 
important part of the immune response to many viral infections; 
however, this system is a target for inhibition by many viruses. 
Identifying a microbiota manipulation (e.g., dietary change or 
components of the innate response. The specificity of microbiota 
effects can be examined by colonizing germ-free mice with spe-
cific types of bacteria to determine whether a particular type of 
bacteria is sufficient to affect the virus of interest. Together, these 
types of experiments will reveal the basics of microbiota–virus 
interactions and will provide information for detailed mechanistic 
studies in the future.
implicAtions for humAn heAlth
It is clear that the microbiota provides a major source of biological 
variation between individuals, and it is a contributor to numerous 
biological processes. Microbiota plasticity, which is significantly 
greater than that of our own genome, may be harnessed to modulate 
aspects of human health, such as optimizing resistance to certain 
pathogens. The link between microbiota perturbation and enteric 
pathogen emergence illustrates that investigation into the factors 
that govern microbiota stability could have great significance for 
humans. Alternatively, if certain members of the microbiota, or 
certain functions encoded within the microbiota, are co-opted 
by viruses and are required for invasion of host tissue, this set of 
interactions presents new therapeutic targets.
Figure 1 | Potential roles that commensal microbes within the intestine 
may play in host susceptibility to virus. (A) A commensal may inhibit a virus 
(top left panel) directly (a), or indirectly at a local site (b), or at a peripheral site 
such as the lung (c). Conversely, this same commensal may promote viral 
infectivity (lower left panel) via these same mechanisms, such as directly 
activating the virus (a), recruiting leukocytes that promote/permit viral replication 
(b), or setting systemic immune parameters that are permissive for viral 
replication at a distant site (c). (B) Other commensals may have opposite effects 
on the same viruses, and alterations in microbiota composition or functional 
state may shift the balance in favor of the first or second scenario.
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of how the relationship between the microbiota and mucosal 
immune system may be optimized to reduce viral disease and to 
improve the efficacy of oral vaccines.
A logical and likely extension of personal genomes is the per-
sonal microbiome, elucidating the genes encoded by the core species 
or taxa within an individual’s intestine. With ever the increasing 
understanding of how the biology of host and microbiota integrate, 
these two sets of DNA sequences will offer insight into current or 
looming pathologies by identifying potential deleterious combina-
tions of polymorphisms in the genes of host and microbiota. The 
microbiome offers a set of genes much more amenable to manipu-
lation compared to our human genome. A prerequisite for incor-
porating the microbiota into personalized, preventative medicine 
is to attain a mechanistic understanding of microbiota function 
and to understand how microbes within the intestine affect the 
resistance and susceptibility to pathogens (Nicholson et al., 2005; 
Zaneveld et al., 2008). The rational manipulation of our “microbial 
self” will soon be a reality, and it is imperative to understand which 
manipulations will promote human health.
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probiotic administration) that induces a mild anti-viral-like IFN 
response suggests a strategy for pre-conditioning the host immune 
response to provide increased resistance during periods of height-
ened vulnerability (e.g., in infancy or during epidemics). Tuning 
the immune rheostat to desired set-points using microbial expo-
sure (i.e., colonization status) provides a promising avenue that 
may have broad applicability. Identification of biomarkers of these 
host responses, which can be surveyed in feces, urine, or blood, 
will enable these responses to be tracked and appropriately altered.
The ability to modulate the status of the mucosal immune sys-
tem has implications for improving the efficacy of oral vaccination 
campaigns. One such example is the global effort to eradicate wild 
poliovirus, which has stalled in recent years due to the failure of 
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oping nations. In the Indian states of Uttar Pradesh and Bihar, 
less than 71% of children are protected against type 1 poliovirus 
despite an average of 15 oral doses of trivalent vaccine per child 
before 5 years of age; 85% protection is achieved with 10 average 
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